|
Volumn 59, Issue 11, 2013, Pages 1553-1555
|
Scanning for cancer genomic changes in plasma: Toward an era of personalized blood-based tumor markers
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 15-3 ANTIGEN;
DNA FRAGMENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GLYCOPROTEIN;
PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE;
PROTEIN P53;
BREAST CANCER;
BREAST METASTASIS;
CANCER DIAGNOSIS;
CANCER GENETICS;
CANCER GROWTH;
CANCER PATIENT;
CANCER PROGNOSIS;
CANCER SIZE;
CARCINOGENESIS;
CHROMOSOME ABERRATION;
CIRCULATING TUMOR CELL;
DNA DETERMINATION;
EARLY CANCER;
ENZYME ACTIVE SITE;
GENE AMPLIFICATION;
GENETIC MARKER;
GENOME ANALYSIS;
INOPERABLE CANCER;
LUNG NON SMALL CELL CANCER;
OCCULT CANCER;
POINT MUTATION;
POISSON DISTRIBUTION;
PROTEIN BLOOD LEVEL;
REVIEW;
SINGLE NUCLEOTIDE POLYMORPHISM;
SOMATIC MUTATION;
TREATMENT RESPONSE;
WILD TYPE;
|
EID: 84887106523
PISSN: 00099147
EISSN: 15308561
Source Type: Journal
DOI: 10.1373/clinchem.2013.207381 Document Type: Review |
Times cited : (14)
|
References (5)
|